scispace - formally typeset
Open AccessJournal ArticleDOI

2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk

TLDR
Authors/Task Force Members (François Macha, Colin Baigentb,∗∗,2, Alberico L. Catapanoc), ESC Committee for Practice Guidelines (CPG) (Stephan Windeckeraa), ESC National Cardiac Societies (Djamaleddine Nibouchean, Parounak H. Patelcl)
About
This article is published in Atherosclerosis.The article was published on 2019-09-02 and is currently open access. It has received 2972 citations till now. The article focuses on the topics: Lipid modification & Very low-density lipoprotein.

read more

Citations
More filters

Standards of Medical Care in Diabetes

TL;DR: These standards of care are intended to provide clinicians, patients, researchers, payors, and other interested individuals with the components of diabetes care, treatment goals, and tools to evaluate the quality of care.
Journal ArticleDOI

2021 ESC Guidelines on cardiovascular disease prevention in clinical practice

Frank L.J. Visseren, +105 more
Journal Article

Effects of the amount and intensity of exercise on plasma lipoproteins: Editor's comments

TL;DR: The highest amount of weekly exercise, with minimal weight change, had widespread beneficial effects on the lipoprotein profile, seen most clearly with the high amount of high-intensity exercise.
Journal ArticleDOI

Atorvastatin in Patients With Type 2 Diabetes Mellitus Undergoing Hemodialysis

TL;DR: Atorvastatin had no statistically significant effect on the composite primary end point of cardiovascular death, nonfatal myocardial infarction, and stroke in patients with diabetes receiving hemodialysis.
References
More filters
Journal ArticleDOI

Effect of statins on venous thromboembolic events: A meta-analysis of published and unpublished evidence from randomised controlled trials

TL;DR: A systematic review and meta-analysis conducted by Kazem Rahimi and colleagues re-evaluates the hypothesis, generated in previous studies, that statins may reduce the risk of venous thromboembolic events and does not support the previous findings.
Journal ArticleDOI

Lipoprotein(a) and Cardiovascular Risk Prediction Among Women.

TL;DR: In 3 cohorts of women, Lp(a) was associated with CVD only among those with high TC, and improvement in prediction was minimal, which has implications for Lp (a) in clinical practice among women and for trials of L p(a)-lowering agents.

Effect of statins on venous thromboembolic events: a meta-analysis of published and unpublished evidence from randomised controlled trials [abstract, poster presentation].

Kazem Rahimi
TL;DR: In this paper, a systematic review and meta-analysis conducted by Kazem Rahimi and colleagues re-evaluated the hypothesis, generated in previous studies, that statins may reduce the risk of venous thromboembolic events.
Related Papers (5)

2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular riskThe Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS)

François Mach, +120 more